Gene mutations play critically important role in acute myeloid leukemia; Promising development for new treatments

The key to treating one of the most common types of human leukemia may lie within mutations in a gene called FLT3, according to new research. The work validates certain activating mutations in the FLT3 gene as targets for acute myeloid leukemia therapy — a critically important finding for developing drugs.